Enteral Levodopa Therapy in Advanced Parkinson's Disease with Gastroparesis.
作者信息
Venkitachalam Anil, Lazarescu Adriana, Suchowersky Oksana
机构信息
Division of Neurology Department of Medicine University of Alberta Edmonton Alberta Canada.
Division of Gastroenterology Department of Medicine University of Alberta Edmonton Alberta Canada.
出版信息
Mov Disord Clin Pract. 2015 Jun 4;2(3):321-322. doi: 10.1002/mdc3.12189. eCollection 2015 Sep.
Abstract
摘要
相似文献
1
Enteral Levodopa Therapy in Advanced Parkinson's Disease with Gastroparesis.晚期帕金森病合并胃轻瘫的肠内左旋多巴治疗
Mov Disord Clin Pract. 2015 Jun 4;2(3):321-322. doi: 10.1002/mdc3.12189. eCollection 2015 Sep.
2
Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients.左旋多巴-卡比多巴肠凝胶对晚期帕金森病患者运动障碍的影响。
Mov Disord. 2016 Apr;31(4):530-7. doi: 10.1002/mds.26528. Epub 2016 Jan 28.
3
Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease.左旋多巴-卡比多巴肠凝胶治疗晚期帕金森病的长期安全性和疗效。
Mov Disord. 2018 Jul;33(6):928-936. doi: 10.1002/mds.27338. Epub 2018 Mar 23.
4
[Application of levodopa/carbidopa intestinal gel in advanced Parkinson's disease].左旋多巴/卡比多巴肠凝胶在晚期帕金森病中的应用
Neuropsychopharmacol Hung. 2015 Dec;17(4):191-6.
5
Transcutaneous port for levodopa/carbidopa intestinal gel administration in Parkinson's disease.用于帕金森病中左旋多巴/卡比多巴肠凝胶给药的经皮端口
Acta Neurol Scand. 2016 Mar;133(3):208-15. doi: 10.1111/ane.12464. Epub 2015 Jul 24.
6
Continuous intra jejunal infusion of levodopa-carbidopa intestinal gel by jejunal extension tube placement through percutaneous endoscopic gastrostomy for patients with advanced Parkinson's disease: a preliminary study.通过经皮内镜胃造口术放置空肠延长管对晚期帕金森病患者持续空肠内输注左旋多巴-卡比多巴肠凝胶：一项初步研究。
Eur Rev Med Pharmacol Sci. 2016 Jun;20(11):2413-7.
7
[Levodopa-carbidopa intestinal gel treatment introduced by surgical gastrostomy in a patient of Parkinson's disease after Billroth II gastrojejunostomy].[在毕罗Ⅱ式胃空肠吻合术后的帕金森病患者中，经手术胃造口术引入左旋多巴-卡比多巴肠凝胶治疗]
Rinsho Shinkeigaku. 2018 Sep 28;58(9):570-573. doi: 10.5692/clinicalneurol.cn-001150. Epub 2018 Aug 31.
8
The use of enteral access for continuous delivery of levodopa-carbidopa in patients with advanced Parkinson's disease.在晚期帕金森病患者中使用肠内通路持续输注左旋多巴-卡比多巴。
United European Gastroenterol J. 2017 Feb;5(1):60-68. doi: 10.1177/2050640616650804. Epub 2016 Jun 23.
9
[Characteristics of levodopa treatment in advanced Parkinson's disease in the experiences of the neurology clinics of Târgu Mureș, Romania].[罗马尼亚特尔古穆列什神经病学诊所经验中晚期帕金森病左旋多巴治疗的特点]
Orv Hetil. 2019 Apr;160(17):662-669. doi: 10.1556/650.2019.31354.
10
Carbidopa levodopa enteral suspension.卡比多巴左旋多巴肠内悬浮液。
Expert Opin Pharmacother. 2015;16(18):2807-17. doi: 10.1517/14656566.2015.1111336. Epub 2015 Nov 23.
引用本文的文献
1
Comparison Between Levodopa-Carbidopa Intestinal Gel Infusion and Subthalamic Nucleus Deep-Brain Stimulation for Advanced Parkinson's Disease: A Systematic Review and Meta-Analysis.左旋多巴-卡比多巴肠凝胶输注与丘脑底核深部脑刺激治疗晚期帕金森病的比较：一项系统评价和荟萃分析
Front Neurol. 2019 Aug 27;10:934. doi: 10.3389/fneur.2019.00934. eCollection 2019.
2
Pharmacological Insights into Levodopa-induced Motor Fluctuations in Patients with Parkinson's Disease.帕金森病患者左旋多巴诱发运动波动的药理学见解
Mov Disord Clin Pract. 2016 Sep 4;3(6):523-526. doi: 10.1002/mdc3.12389. eCollection 2016 Nov-Dec.
本文引用的文献
1
Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results.左旋多巴-卡比多巴肠凝胶用于晚期帕金森病：12个月最终开放标签研究结果
Mov Disord. 2015 Apr;30(4):500-9. doi: 10.1002/mds.26123. Epub 2014 Dec 24.
2
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study.连续肠内输注左旋多巴-卡比多巴肠凝胶治疗晚期帕金森病患者的随机、对照、双盲、双模拟研究。
Lancet Neurol. 2014 Feb;13(2):141-9. doi: 10.1016/S1474-4422(13)70293-X. Epub 2013 Dec 20.
3
Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience.左旋多巴/卡比多巴肠凝胶输注治疗晚期帕金森病：7年经验
Eur J Neurol. 2014 Feb;21(2):312-8. doi: 10.1111/ene.12309. Epub 2013 Dec 7.
4
Post-pyloric feeding.幽门后喂养
World J Gastroenterol. 2009 Mar 21;15(11):1281-8. doi: 10.3748/wjg.15.1281.
5
The pharmacokinetics and pharmacodynamics of levodopa in the treatment of Parkinson's disease.左旋多巴治疗帕金森病的药代动力学和药效学
Curr Clin Pharmacol. 2007 Sep;2(3):234-43. doi: 10.2174/157488407781668802.
6
Gastric emptying time and gastric motility in patients with Parkinson's disease.帕金森病患者的胃排空时间和胃动力
Mov Disord. 2001 Nov;16(6):1041-7. doi: 10.1002/mds.1203.
Zotero 插件